Respiratory syncytial virus-associated hospitalisation in adults with comorbidities in two European countries: amodelling study

Authors:

Richard Osei-Yeboah et al.

Respiratory syncytial virus (RSV) is a major cause of respiratory tract infections (RTI), and leads to about 245,000 and 158,000 hospitalisations annually in young children and adults aged 18 years and older respectively in EU countries, with a disproportionate burden occurring in infants and adults aged 65 years and older [1, 2]. Besides older age, comorbidities are a key risk factor for RSV hospitalisation in the adult population.